Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | AZD-2281 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0009 |
mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
mRNA | VX-680 | CTRPv2 | pan-cancer | AAC | 0.34 | 0.002 |
mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | 0.091 | 0.002 |
mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | 0.091 | 0.003 |
mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | 0.091 | 0.004 |
mRNA | chlorambucil | CTRPv2 | pan-cancer | AAC | 0.086 | 0.005 |
mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | 0.082 | 0.005 |
mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | 0.086 | 0.005 |
mRNA | YK 4-279 | CTRPv2 | pan-cancer | AAC | 0.087 | 0.005 |